Genetic Testing Fuels Growth in Inherited Cardiomyopathy Diagnosis

added blog Health

2025-06-20 05:23:39

The Global Dilated Cardiomyopathy (DCM) Therapeutics Market is poised for robust growth, projected to increase from USD 1.1 billion in 2023 to USD 1.7 billion by 2031, growing at a compound annual growth rate (CAGR) of 5.7% during the forecast period. The increasing burden of heart failure globally, advances in genetic testing, and expanding access to targeted therapies are major forces driving...

0 Comments 0 Shares 442 Views 0 Reviews